February 3, 2016 9:07am
50% of Patients Enrolled in NeoCart P3 Clinical Trial and sees enrollment completion by 2017.
HSGX has had more than a few positive and upside days while the sector and market has been hammered – a positive sign.
The light has turned GREEN and it’s time to ... read more ...
Members only. Please login.